Literature DB >> 27328498

Umbilical arterial N-terminal pro-B-type natriuretic peptide levels in preeclampsia, fetal growth restriction, preterm birth and fetal distress.

J Y Bae, W J Seong.   

Abstract

OBJECTIVE: To evaluate fetal cardiopulmonary stress in pregnancies complicated by preeclampsia (PE), fetal growth restriction (FGR), preterm birth (PT), and fetal distress (FD) using umbilical arterial blood N-terminal pro-B-type natriuretic peptide (NT-proBNP).
MATERIALS AND METHODS: The study included 146 blood samples that were drawn from umbilical arteries at the time of delivery (20 cases of PE, 11 cases of FGR, 31 cases of PT, 23 cases of FD, and 61 cases of gestational age-matched controls) and analyzed. The main outcome measures included neonatal birthweight, cord pH, and umbilical arterial NT-proBNP.
RESULTS: The umbilical arterial NT-proBNP levels were significantly higher in the PE, FGR, PT, and FD groups than in the control group. The umbilical arterial NT-proBNP levels were negatively correlated with gestational age, birthweight, and umbilical arterial pH.
CONCLUSIONS: Umbilical arterial NT-proBNP levels are elevated in stressful fetal conditions and have the potential to be considered as a marker for fetal cardiopulmonary stress.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27328498

Source DB:  PubMed          Journal:  Clin Exp Obstet Gynecol        ISSN: 0390-6663            Impact factor:   0.146


  2 in total

1.  The relationship between maternal vitamin D deficiency and glycolipid metabolism and adverse pregnancy outcome.

Authors:  Hai-Ying Chen; Hong-Ping Zhang; Jie Yang; Zhi-Qiong Huang; Hai-Xia Xu; Jiang Jin; Kai Xu; Yu Tong; Qian-Qian Dong; Jian-Qiong Zheng
Journal:  Clin Endocrinol (Oxf)       Date:  2020-09-02       Impact factor: 3.478

2.  The Role of Slit-2 in Gestational Diabetes Mellitus and Its Effect on Pregnancy Outcome.

Authors:  Yan Wang; Shihua Zhao; Wei Peng; Ying Chen; Jingwei Chi; Kui Che; Yangang Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-23       Impact factor: 6.055

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.